• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of altered expression of and as an early diagnostic approach in gastric cancer.评估[具体基因名称1]和[具体基因名称2]的表达改变作为胃癌早期诊断方法的研究。 需注意,原文中“ and ”处应补充具体基因名称,这里是按照完整句子结构和翻译要求给出的示例译文,实际应用中需根据准确内容翻译。
J Gastrointest Oncol. 2018 Feb;9(1):46-51. doi: 10.21037/jgo.2017.11.04.
2
Evaluation of miR-22 and miR-20a as diagnostic biomarkers for gastric cancer.评估miR-22和miR-20a作为胃癌诊断生物标志物的价值。
Chin Clin Oncol. 2017 Apr;6(2):16. doi: 10.21037/cco.2017.03.01.
3
Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.DNA甲基化上调循环miR-106a有望成为胃癌潜在的诊断和预后标志物。
Anticancer Agents Med Chem. 2016;16(9):1093-100. doi: 10.2174/1871520615666150716110657.
4
Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.胃泌素 MicroRNAs 作为胃癌筛查的潜在生物标志物。
Cancer. 2013 May 1;119(9):1618-26. doi: 10.1002/cncr.27903. Epub 2013 Jan 18.
5
A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.血清外泌体微小RNA检测 panel作为胃癌的潜在生物标志物检测方法
Biochem Biophys Res Commun. 2017 Nov 25;493(3):1322-1328. doi: 10.1016/j.bbrc.2017.10.003. Epub 2017 Oct 3.
6
Detection of miR-106a in gastric carcinoma and its clinical significance.胃癌中miR-106a的检测及其临床意义。
Clin Chim Acta. 2009 Feb;400(1-2):97-102. doi: 10.1016/j.cca.2008.10.021. Epub 2008 Oct 30.
7
LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.LINC01133 通过海绵吸附 miR-106a-3p 来抑制胃癌进展,从而调节 APC 表达和 Wnt/β-catenin 通路。
Mol Cancer. 2018 Aug 22;17(1):126. doi: 10.1186/s12943-018-0874-1.
8
Diagnostic significance of miR-106a in gastric cancer.miR-106a在胃癌中的诊断意义
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13096-101. eCollection 2015.
9
Transcription factor KLF4 modulates microRNA-106a that targets Smad7 in gastric cancer.转录因子 KLF4 调节 microRNA-106a,后者靶向胃癌中的 Smad7。
Pathol Res Pract. 2019 Aug;215(8):152467. doi: 10.1016/j.prp.2019.152467. Epub 2019 May 23.
10
Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.X 染色体上 miR-106a-363 簇的循环 microRNAs 作为乳腺癌的新型诊断生物标志物。
Breast Cancer Res Treat. 2018 Jul;170(2):257-270. doi: 10.1007/s10549-018-4757-3. Epub 2018 Mar 20.

引用本文的文献

1
Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells.浙贝母碱增强阿霉素对人胃腺癌细胞的细胞毒性并下调hsa-miR-106a-5p和hsa-miR-181a-5p
Adv Biomed Res. 2024 Dec 28;13:121. doi: 10.4103/abr.abr_535_23. eCollection 2024.
2
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion.胃肠道癌中的肿瘤微环境重塑:微小RNA作为肿瘤侵袭生物标志物的作用
Biomedicines. 2023 Jun 19;11(6):1761. doi: 10.3390/biomedicines11061761.
3
Long non-coding RNA GASL1 restrains gastric carcinoma cell proliferation and metastasis by sponging microRNA-106a.长链非编码 RNA GASL1 通过海绵吸附 microRNA-106a 抑制胃癌细胞增殖和转移。
Cell Cycle. 2020 Oct;19(20):2611-2621. doi: 10.1080/15384101.2020.1812918. Epub 2020 Sep 8.
4
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.胃食管癌中的分子生物标志物:最新进展、当前趋势及未来方向
Cancer Cell Int. 2018 Jul 11;18:99. doi: 10.1186/s12935-018-0594-z. eCollection 2018.

本文引用的文献

1
MicroRNAs in cancer.微小 RNA 与癌症。
Annu Rev Pathol. 2014;9:287-314. doi: 10.1146/annurev-pathol-012513-104715. Epub 2013 Sep 25.
2
Biomarkers of Helicobacter pylori-associated gastric cancer.幽门螺杆菌相关性胃癌的生物标志物。
Gut Microbes. 2013 Nov-Dec;4(6):532-40. doi: 10.4161/gmic.25720. Epub 2013 Jul 12.
3
Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.胃癌中 miR-22 的表达降低与临床病理特征或患者预后相关。
Diagn Pathol. 2013 Jun 21;8:102. doi: 10.1186/1746-1596-8-102.
4
Clinical application of microRNA in gastric cancer in Eastern Asian area.东亚地区微小 RNA 在胃癌中的临床应用。
World J Gastroenterol. 2013 Apr 7;19(13):2019-27. doi: 10.3748/wjg.v19.i13.2019.
5
MicroRNAs as diagnostic biomarkers in gastric cancer.微小RNA作为胃癌的诊断生物标志物
Int J Mol Sci. 2012 Oct 1;13(10):12544-55. doi: 10.3390/ijms131012544.
6
Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma.比较术前和术后血浆 miRNA 芯片中胃癌相关 microRNAs 的检测。
Br J Cancer. 2012 Feb 14;106(4):740-7. doi: 10.1038/bjc.2011.588. Epub 2012 Jan 19.
7
Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.全基因组 microRNA 谱分析鉴定 miR-378 作为胃癌早期检测的血清生物标志物。
Cancer Lett. 2012 Mar 28;316(2):196-203. doi: 10.1016/j.canlet.2011.10.034. Epub 2011 Nov 2.
8
Aberrant hypermethylation of miR-9 genes in gastric cancer.胃癌中 miR-9 基因的异常甲基化。
Epigenetics. 2011 Oct 1;6(10):1189-97. doi: 10.4161/epi.6.10.16535.
9
Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.鉴定肠型胃癌中异常表达的新 miRNAs 及其临床意义。
Oncol Rep. 2011 Dec;26(6):1431-9. doi: 10.3892/or.2011.1437. Epub 2011 Aug 24.
10
MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.miR-9 的上调通过促进细胞迁移参与结直肠癌的转移。
Med Oncol. 2012 Jun;29(2):1037-43. doi: 10.1007/s12032-011-9975-z. Epub 2011 May 12.

评估[具体基因名称1]和[具体基因名称2]的表达改变作为胃癌早期诊断方法的研究。 需注意,原文中“ and ”处应补充具体基因名称,这里是按照完整句子结构和翻译要求给出的示例译文,实际应用中需根据准确内容翻译。

Evaluation of altered expression of and as an early diagnostic approach in gastric cancer.

作者信息

Shirmohammadi Khadije, Sohrabi Sareh, Jafarzadeh Samani Zahra, Effatpanah Hosein, Yadegarazari Reza, Saidijam Massoud

机构信息

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

出版信息

J Gastrointest Oncol. 2018 Feb;9(1):46-51. doi: 10.21037/jgo.2017.11.04.

DOI:10.21037/jgo.2017.11.04
PMID:29564170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5848032/
Abstract

BACKGROUND

The role of microRNAs (miRNAs) in cellular processes such as growth, apoptosis, differentiation and proliferation verifies the importance of miRNAs in carcinogenesis. Moreover, levels of miRNAs are dysregulated in cancer cells, so they could be used as novel classes of biomarkers for diagnosing cancer. The oncogenic role of and its increased expression have been demonstrated in some cancers. In contrast, there is no consensus for expression rate in different cancers. Therefore, this study was done to investigate the role of and in gastric cancer (GC).

METHODS

The current study was performed on 31 GC tissues as case, and 31 healthy adjacent tissues as a control group. Quantitative reverse transcriptase (q-RT) PCR was used for studying the expression rate of both and .

RESULTS

The expression rate of both miRNAs in cancerous tissues was significantly higher than healthy adjacent tissues (≈10 folds) (P<0.05).

CONCLUSIONS

The results showed that the expression rate of both markers was significantly increased in cancerous tissues. Therefore, they can be suggested as potential biomarkers for cancer diagnosis and prognosis as well as targets for therapy.

摘要

背景

微小RNA(miRNA)在细胞生长、凋亡、分化和增殖等过程中的作用证实了其在肿瘤发生中的重要性。此外,癌细胞中miRNA水平失调,因此它们可作为诊断癌症的新型生物标志物。 的致癌作用及其表达增加已在某些癌症中得到证实。相比之下,不同癌症中 的表达率尚无共识。因此,本研究旨在探讨 和 在胃癌(GC)中的作用。

方法

本研究以31例GC组织为病例组,31例健康相邻组织为对照组。采用定量逆转录(q-RT)PCR研究 和 的表达率。

结果

两种miRNA在癌组织中的表达率均显著高于健康相邻组织(约10倍)(P<0.05)。

结论

结果表明,两种标志物在癌组织中的表达率均显著升高。因此,它们可作为癌症诊断和预后的潜在生物标志物以及治疗靶点。